PEG Share Price Performance
DKK 0.094
-0.09 (-47.86%)
Price DKK 0.094
Share Pricen/a
We Think Pharma Equity Group (CPH:PEG) Has A Fair Chunk Of Debt
Dec 06
Pharma Equity Group A/S Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PEG Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Pharma Equity Group A/S Key Details
About PEG
- Founded
- 2002
- Employees
- n/a
- CEO
- WebsiteView website
Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement. Its products under development that are in Phase II clinical trials include RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of Ulcus Cruris chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouchitis; and RNX-051 for the treatment of colorectal cancer and colon adenoma. The company was incorporated in 2002 and is headquartered in Horsholm, Denmark.
